ArticleJournal of experimental & clinical cancer research : CR2022

SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma.

Rossella Loria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.